×
Human iPSC-CMs and in-silico technologies define mechanisms and accelerate targeted pharmacogenetics in hypertrophic cardiomyopathy
Margara F., Psaras Y., Wang ZJ., Schmid M., Doste R., Garfinkel A., Repetti G., Seidman J., Seidman C., Rodriguez B., Toepfer C., Bueno-Orovio A.
DOI
10.1101/2022.06.08.495324
Type
Preprint
Publication Date
2022-01-01T00:00:00+00:00